Lumida
/AXGN
⌘K
AxoGen Inc

AxoGen Inc

AXGN
$42.16USD+0.74%+0.31 today

MARKET CAP

2.3B

P/E (TTM)

FWD P/E

DAY RANGE

$40 – $43

52W RANGE

$15
$53

AI Summary

Stalk
StalkMedium

AXGN exhibited a terminal Capitulation (Final Flush) bar on extreme volume, signaling forced liquidation is ending and setting up a potential reflex rally within the long-term uptrend. Medium-term directional asymmetry shifts bullish given the terminal pattern, but price remains extended below the 9- and 21-day EMAs without evidence of stabilization. Execution should be deferred (Stalk) and focused on pullback absorption or early signs of a hold near intermediate moving averages before buying.

  • Q2 revenue +23.1% YoY to $69.7M, driven by surgeon engagement
  • Breast segment revenue +50% YoY, boosting overall growth
  • Q2 gross margin fell to 72.7% from 74.2% due to costlier breast procedures
Full analysis →
Insider Trades35 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 10, 2026SellAXGNMarc A BeganEVP & General Counsel135,000$27.75$2.3B-20.32%+176.10%$3.7M+0.00%10b5-1Sell Now
May 7, 2026BuyAXGNLindsey Marie HartleyCFO6,514$13.95$2.3B-20.32%+176.10%$90.9K+1.75%Sell Now
May 7, 2026SellAXGNDoris QuackenbushSales VP3,878$43.51$2.3B-20.32%+176.10%$168.7K-4.03%Sell Now
May 7, 2026SellAXGNJens KempChief Marketing Officer4,000$43.44$2.3B-20.32%+176.10%$173.8K-5.23%Sell Now
Mar 16, 2026SellAXGNLindsey Marie HartleyCFO3,542$32.84$2.3B-20.32%+176.10%$116.3K-2.70%Sell Now
Mar 16, 2026SellAXGNErick Wayne DevinneyChief Innovation Officer8,091$32.84$2.3B-20.32%+176.10%$265.7K-1.48%Sell Now
Feb 26, 2026SellAXGNLindsey Marie HartleyCFO6,630$31.90$2.3B-20.32%+176.10%$211.5K-7.81%Sell Now
Feb 26, 2026SellAXGNMarc A BeganEVP & General Counsel13,180$31.48$2.3B-20.32%+176.10%$414.9K-9.36%Sell Now
Feb 26, 2026SellAXGNJens KempChief Marketing Officer18,366$31.70$2.3B-20.32%+176.10%$582.2K-9.31%Sell Now
Feb 26, 2026SellAXGNErick Wayne DevinneyChief Innovation Officer21,978$31.26$2.3B-20.32%+176.10%$687.0K-3.91%Sell Now
Feb 22, 2026SellAXGNLindsey Marie HartleyCFO6,704$35.38$2.3B-20.32%+176.10%$237.2K-9.76%Sell Now
Dec 15, 2025SellAXGNLindsey Marie HartleyCFO29,624$19.07$2.3B-20.32%+176.10%$564.8K+0.00%Sell Now
Dec 11, 2025SellAXGNMarc A BeganEVP & General Counsel13,222$30.00$2.3B-20.32%+176.10%$396.7K-41.97%Sell Now
Dec 10, 2025SellAXGNMichael D DaleChief Executive Officer25,000$30.00$2.3B-20.32%+176.10%$750.0K-28.24%Sell Now
Dec 9, 2025SellAXGNJens KempChief Marketing Officer8,156$31.21$2.3B-20.32%+176.10%$254.5K-15.05%Sell Now
Dec 9, 2025SellAXGNMarc A BeganEVP & General Counsel9,278$31.21$2.3B-20.32%+176.10%$289.5K-22.75%Sell Now
Dec 9, 2025SellAXGNErick Wayne DevinneyChief Innovation Officer19,517$31.21$2.3B-20.32%+176.10%$609.1K-7.49%Sell Now
Dec 9, 2025SellAXGNMichael D DaleChief Executive Officer61,463$31.21$2.3B-20.32%+176.10%$1.9M-40.98%Sell Now
Dec 8, 2025BuyAXGNLindsey Marie HartleyCFO39,387$20.30$2.3B-20.32%+176.10%$799.4K+7.37%Sell Now
Sep 16, 2025SellAXGNErick Wayne DevinneyChief Innovation Officer1,137$16.29$2.3B-20.32%+176.10%$18.5K-0.51%Sell Now
Mar 19, 2025SellAXGNErick Wayne DevinneyChief Innovation Officer15,111$17.50$2.3B-20.32%+176.10%$264.4K-5.76%Sell Now
Mar 4, 2025SellAXGNJens KempChief Marketing Officer4,003$18.36$2.3B-20.32%+176.10%$73.5K-12.63%Sell Now
Mar 4, 2025SellAXGNMarc A BeganEVP & General Counsel5,901$18.36$2.3B-20.32%+176.10%$108.3K-12.64%Sell Now
Mar 4, 2025SellAXGNErick Wayne DevinneyChief Innovation Officer8,296$18.35$2.3B-20.32%+176.10%$152.2K-3.96%Sell Now
Feb 25, 2025SellAXGNJens KempChief Marketing Officer814$16.49$2.3B-20.32%+176.10%$13.4K-32.56%Sell Now
Feb 25, 2025SellAXGNJens KempChief Marketing Officer814$16.49$2.3B-20.32%+176.10%$13.4K-2.50%Sell Now
Feb 25, 2025SellAXGNMarc A BeganEVP & General Counsel814$16.50$2.3B-20.32%+176.10%$13.4K-32.56%Sell Now
Feb 25, 2025SellAXGNErick Wayne DevinneyChief Innovation Officer972$16.50$2.3B-20.32%+176.10%$16.0K-0.52%Sell Now
Jan 6, 2025SellAXGNNir NaorCFO39,132$15.22$2.3B-20.32%+176.10%$595.6K-13.04%Sell Now
Mar 21, 2024SellAXGNErick Wayne DevinneyChief Innovation Officer4,578$7.68$2.3B-20.32%+176.10%$35.2K-0.86%Sell Now
Mar 21, 2024SellAXGNMichael Patrick DonovanVP Operations6,033$7.68$2.3B-20.32%+176.10%$46.3K-3.77%Sell Now
Mar 21, 2024SellAXGNAngelo ScopelianosChief R&D Officer6,881$7.68$2.3B-20.32%+176.10%$52.8K-3.45%Sell Now
Mar 21, 2024SellAXGNKaren L. ZaderejCEO39,280$7.68$2.3B-20.32%+176.10%$301.7K-1.11%Sell Now
Mar 7, 2024SellAXGNMichael Patrick DonovanVP Operations36,310$8.81$2.3B-20.32%+176.10%$319.9K-50.42%Sell Now
Dec 11, 2023SellAXGNPeter J MarianiEVP & Chief Financial Officer12,500$7.50$2.3B-20.32%+176.10%$93.8K-5.62%Sell Now